Using a strategy that tracks cancer cells' consumption of nucleosides, a team of researchers at UCLA's Jonsson Comprehensive Center has identified a group of liposarcoma tumors that can be imaged by PET scanning using a tracer substance known as FAC. Furthermore, they have found that these tumors are sensitive to chemotherapy. The team's findings are published online in the journal Cancer Discovery. Read more here.
Study mentioned: Braas D, et al. Metabolomics Strategy Reveals Subpopulation of Liposarcomas Sensitive to Gemcitabine Treatment. Cancer Discov. 2012 Dec;2(12):1109-1117. PMID: 23230188
No comments:
Post a Comment